Recipharm buys IUD-pain drug firm Pharmanest as part of consortium
Recipharm has acquired a 25% stake in topical drug developer Pharmanest as part of an investment consortium.
Archives for July 8, 2015
Epic Sciences expands partnership with LabCorp’s Covance in Asia
Epic and LabCorp’s Covance have agreed to extend their partnership to provide circulating tumor cell (CTC) technology and oncology clinical trial support in Asia.
FDA rule requires drugmakers to report manufacturing disruptions six months in advance
A new final rule from the US FDA now requires all drug and biologic manufacturers to notify the agency electronically of a permanent discontinuance or an interruption in manufacturing six months in advance, or as soon as is practical, before the...
Mylan recalls cancer and arthritis injectables
Mylan is expanding its recall of injectable Gemcitabine and Methotrexate batches after finding visible particulates.
Lupin enters Russian market through Biocom deal
Lupin is set to acquire Russian generics maker Biocom, adding a GMP compliant facility and gaining access to the local market.
Private CRO expands into Armenia
US and China-based CRO FMD K&L has expanded into Armenia with a new office to support clients’ needs in the region and grow the company’s business further in Europe.
Beast of bio-burden: Charles River to buy bacterial test firm Celsis
Charles River is set to buy QC company Celsis in a $212m deal to expand its Endotoxin and Microbial Detection business.
TTIP: MEPs back investor-friendly legal system proposal despite opposition
Proposed amendments to TTIP backed by MEPs will either encourage foreign investment or allow US drug firms to sue EU states whose laws restrict profits, depending who you ask.